A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists

Novo Nordisk

Status

Completed

Conditions

Atherosclerotic Cardiovascular Disease (ASCVD)

Systemic Inflammation

Chronic Kidney Disease (CKD)

Treatments

Other: No treatment given

Study type

Observational

Funder types

Industry

Identifiers

NCT06322641

U1111-1303-3089 (Other Identifier)

DAS-8092

Details and patient eligibility

About

The purpose of this survey is to collect information for scientific research and to better understand the role of systemic inflammation in identification, treatment and management of patients with Atherosclerotic Cardiovascular Disease (ASCVD) and Chronic Kidney Disease (CKD)

Enrollment

300 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
Male or female, age above or equal to 18 years at the time of signing informed consent.
Is a Nephrologist.
Has been in practice greater than or equal to 3 years.
Sees at least 20 patients with ASCVD and CKD per month.
Treats patients for more than only dialysis

Exclusion criteria

Previous participation in this study. Participation is defined as having given informed consent in this study
Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
Does not meet inclusion criteria requirements